RecruitingNCT05866991
Cohort of Patients Suffering From Major Depressive Episode With Evaluation of Sleep, Circadian Rhythms and Psychiatric Disorders
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
1,000 participants
Start Date
Feb 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Despite international efforts to identify biomarkers of depression, none has been transferred to clinical practice, neither for diagnosis, evolution, nor therapeutic response. This led us to build a French national cohort (through the clinical and research network named SoPsy within the French biological psychiatry society (AFPBN) and sleep society (SFRMS)), to better identify markers of sleep and biological rhythms and validate more homogeneous subgroups of patients, but also to specify the manifestations and pathogeneses of depressive disorders.
Eligibility
Inclusion Criteria3
- Individuals with depressive episode characterized according to the DSM-5 criteria regardless of the associated characteristics and comorbidities.
- Adult and child
- Affiliated to a social security
Exclusion Criteria3
- don't understand or read french
- Medical condition incompatible with administration of questionnaire
- impossibility to give informed decision (subject in an emergency condition, etc.)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05866991
Related Trials
University of Iowa Interventional Psychiatry Service Patient Registry
NCT044809181 location
Presynaptic Imaging in Major Depressive Episodes After COVID-19
NCT060863661 location
Personalized Ultrasonic Brain Stimulation for Depression (R61)
NCT069022981 location
At-Home tDCS as Maintenance Therapy
NCT072699642 locations
Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients
NCT065087104 locations